Baird analyst Catherine Ramsey Schulte raised the firm’s price target on Exact Sciences to $121 from $99 and keeps an Outperform rating on the shares. The firm said they reported another solid quarter, with Cologuard again beating guidance expectations and profitability, including positive FCF continuing to impress.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on EXAS: